Galera therapeutics to participate in the piper sandler 32nd annual virtual healthcare conference

Malvern, pa., nov. 20, 2020 (globe newswire) -- galera therapeutics, inc. (nasdaq: grtx), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced that mel sorensen, m.d., president and chief executive officer, will participate in a fireside chat as part of the piper sandler 32nd annual virtual healthcare conference, being held december 1-3, 2020.
GRTX Ratings Summary
GRTX Quant Ranking